1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Epiomic Epidemiology Series: Tay-Sachs Disease Forecast in 9 Major Markets 2016-2026

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Tay Sachs Disease (TSD) in 9 Major Markets

Hexosaminidase A deficiency (HEX A deficiency) results in a group of neurodegenerative disorders caused by the dysfunctional activity of the specific glycosphingolipid GM2 ganglioside. The disease occurs when cell membrane components known as gangliosides, accumulate to toxic levels, particularly in neurons in the brain and spinal cord, leading to the destruction of neurons and interference with biological functions. The predominant HEX A deficiency is Tay-Sachs disease (TSD) with its common acute infantile variant, which begins around six months of age and usually results in death by the age of four. Alternative variants of the pathology are the juvenile and the adult-onset TSD types.

This report provides the current prevalent population for Tay Sachs disease across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Tay-Sachs have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Tay-Sachs disease include:

• Visual problems
• Low muscle tone
• Seizures
• Neuromuscular abnormalities
• Speech disturbances
• Cerebellar dysfunctions/Impaired cognitive status

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Tay-Sachs disease’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Tay-Sachs disease and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Tay-Sachs disease prevalent population.
• Identify sub-populations within Tay-Sachs disease which require treatment.
• Gain an understanding of the specific markets that have the largest number of Tay-Sachs disease patients.

Table Of Contents

Epiomic Epidemiology Series: Tay-Sachs Disease Forecast in 9 Major Markets 2016-2026
Table of Contents
- List of Tables and Figures
- Introduction
- Cause of the Disease
- Risk Factors and Prevention
- Diagnosis of the Disease
- Variation by Geography/Ethnicity
- Disease Prognosis and Clinical Course
- Key Co-morbid Conditions /Features Associated with the Disease
- Methodology for Quantification of Patient Numbers
- Top-Line Prevalence for TSD
o Genetic Features of TSD Patients
o TSD Phenotype Classification
o Co-morbidities within Infantile TSD
o Co-morbidities within Late-Onset TSD
- Abbreviations used in the Report
- Other Black Swan Analysis Publications
- Black Swan Analysis Online Patient-Based Databases
- Patient-Based Offering
- Online Pricing Data and Platforms
- References
- Appendix


List of Tables
- Prevalence of Tay-Sachs Disease, total (000s)
- Prevalence of Tay-Sachs Disease, males (000s)
- Prevalence of Tay-Sachs Disease, females (000s)
- Prevalence of class of variant alleles of Tay-Sachs patients, total (000s)
- Prevalence of Tay-Sachs patients by phenotype, total (000s)
- Low muscle tone in infantile Tay-Sachs patients, total (000s)
- Seizures in infantile Tay-Sachs patients, total (000s)
- Visual problems in infantile Tay-Sachs patients, total (000s)
- Neuromuscular abnormalities in Late-onset Tay-Sachs Disease, total (000s)
- Speech disturbances in Late-onset Tay-Sachs Disease, total (000s)
- Impaired Cognitive status in Late-onset Tay-Sachs Disease, total (000s)
- Abbreviations and acronyms used in the report
- USA Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- USA Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- France Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- France Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- Germany Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- Germany Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- Italy Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- Italy Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- Spain Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- Spain Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- United Kingdom Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- United Kingdom Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- Brazil Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- Brazil Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- Japan Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- Japan Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)
- India Prevalence of Tay-Sachs Disease by 5-yr age cohort, males (000s)
- India Prevalence of Tay-Sachs Disease by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.